TANSIFA® Plus

TANSIFA® Plus
Product characteristics

Active substance: No

Therapeutic group: The cardiovascular system. Drugs that affect the renin-angiotensin system. Angiotensin II antagonists, combinations. Angiotensin II antagonists, other combinations. Candesartan, amlodipine and hydrochlorothiazide. ATC CODE C09DX06

Form: 14 tablets are placed in a contoured cell package made of a white polyvinyl chloride/ polyethylene/ polyvinylidene chloride (PVC/PE / PVDC) film and a printed aluminum foil. 2 contour cell packages together with instructions for medical use in Kazakh and Russian languages are placed in a cardboard pack.

Package Type: Tablets 16 mg/12.5 mg/5 mg

Download instruction
˄